Literature DB >> 23812022

Does rocuronium-sugammadex reduce myalgia and headache after electroconvulsive therapy in patients with major depression?

Vahap Saricicek1, Levent Sahin, Feridun Bulbul, Sevgi Ucar, Mehrican Sahin.   

Abstract

BACKGROUND: We aimed to compare the effects of succinylcholine and rocuronium-sugammadex on development of myalgia and headache after electroconvulsive therapy (ECT).
METHODS: Forty-five patients undergoing ECT were enrolled in the study. Anesthesia induction was provided with propofol 1 mg/kg intravenously (IV) + succinylcholine 1 mg/kg IV in group S (n = 24) and propofol 1 mg/kg IV + rocuronium 0.3 mg/kg IV in group R (n = 21). Sugammadex 4 mg/kg IV was administered to group R after the motor seizure. The first 3 ECT sessions were evaluated on the basis of time to onset of spontaneous respiration following the induction, time to eye-opening response to verbal stimuli, and visual analog scale (VAS) scores for myalgia and headache at hours 2, 6, 12, and 24 following the ECT for all patients.
RESULTS: The times to onset of spontaneous respiration and eye-opening response to verbal stimuli were significantly shorter in all the 3 sessions in group R compared with group S (P < 0.002). Myalgia VAS scores at hours 2, 6, and 12 and the headache VAS scores at hours 2 and 6 were significantly higher in group S versus group R (P < 0,015).
CONCLUSIONS: We concluded that the rates of myalgia and headache after ECT were significantly lower in group R than in group S, and also the awakening time (spontaneous respiration and opening the eyes in response to verbal stimuli) was significantly shorter in group R compared with group S.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23812022     DOI: 10.1097/YCT.0b013e3182972bd2

Source DB:  PubMed          Journal:  J ECT        ISSN: 1095-0680            Impact factor:   3.635


  5 in total

1.  The Incidence and Predictors of Headache and Myalgia in Patients After Electroconvulsive Therapy (ECT).

Authors:  Mohammad Haghighi; Abbas Sedighinejad; Bahram Naderi Nabi; Cyrus Emiralavi; Gelareh Biazar; Kaveh Mirmozaffari; Cyrus Zahedan; Mehdi Jafari
Journal:  Anesth Pain Med       Date:  2016-03-27

2.  Comparison of emergence agitation between succinylcholine and rocuronium-sugammadex in adults following closed reduction of a nasal bone fracture: a prospective randomized controlled trial.

Authors:  Seok-Jin Lee; Tae-Yun Sung; Choon-Kyu Cho
Journal:  BMC Anesthesiol       Date:  2019-12-16       Impact factor: 2.217

3.  Genomic-Analysis-Oriented Drug Repurposing in the Search for Novel Antidepressants.

Authors:  Mohammad Hendra Setia Lesmana; Nguyen Quoc Khanh Le; Wei-Che Chiu; Kuo-Hsuan Chung; Chih-Yang Wang; Lalu Muhammad Irham; Min-Huey Chung
Journal:  Biomedicines       Date:  2022-08-11

4.  Can Propofol Lead to an Increase in Seizure Threshold Over the Course of Electroconvulsive Therapy?

Authors:  Hande Gurbuz Aytuluk; Tahsin Simsek; Mehmet Yilmaz; Ayse Zeynep Turan; Kemal Tolga Saracoglu
Journal:  Clin Psychopharmacol Neurosci       Date:  2019-11-20       Impact factor: 2.582

Review 5.  Advantages and pitfalls of clinical application of sugammadex.

Authors:  Hyung Young Lee; Ki Tae Jung
Journal:  Anesth Pain Med (Seoul)       Date:  2020-07-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.